Pure Global

Quit & Fit 2.0: Feasibility and Usability Testing - Trial NCT05878990

Access comprehensive clinical trial information for NCT05878990 through Pure Global AI's free database. This phase not specified trial is sponsored by Hackensack Meridian Health and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05878990
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT05878990
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Quit & Fit 2.0: Feasibility and Usability Testing

Study Focus

Smoking Cessation

Culturally-tailored Tobacco Treatment

Interventional

behavioral

Sponsor & Location

Hackensack Meridian Health

Nutley, United States of America

Timeline & Enrollment

N/A

Apr 25, 2023

May 24, 2024

20 participants

Primary Outcome

Feasibility of the 6-week tobacco treatment intervention,Accessibility and Satisfaction of the 6-week tobacco treatment intervention

Summary

Pilot randomized controlled trial to compare tobacco cessation rates of two arms: a 6-week
 culturally tailored tobacco cessation intervention versus a 6-week personalized
 culturally-tailored tobacco cessation intervention among African American women.

ICD-10 Classifications

Mental and behavioural disorders due to use of tobacco withdrawal state
Tobacco use
Exposure to tobacco smoke
Toxic effect: Tobacco and nicotine
Mental and behavioural disorders due to use of tobacco

Data Source

ClinicalTrials.gov

NCT05878990

Non-Device Trial